Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost Raaphorst

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophyJoost Raaphorst, Marianne de Visser, Marie-José van Tol, et al.
Rheumatology (Oxford, England)|December 7, 2021
Assessment of disability in idiopathic inflammatory myopathy: a call for linearityMinoesch Min, Anne W Walter, Johan Lim, et al.
Biomedicines|February 26, 2025
Methodology Development for Investigating Pathophysiological [<sup>18</sup>F]-FDG Muscle Uptake in Patients with Rheumatic Musculoskeletal DiseasesMaia Sobejana, Mustafa Al Beiramani, Gerben J C Zwezerijnen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2021
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysisBas C Stunnenberg, Esther C Merkus, Joost Raaphorst, et al.
Arthritis Research & Therapy|April 1, 2025
Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathwayAna Merino-Vico, Merve Kocyigit, Giulia Frazzei, et al.
Network Neuroscience (Cambridge, Mass.)|July 24, 2025
Longitudinal changes in MEG-based brain network topology of ALS patients with cognitive/behavioral impairment-An exploratory studyRosanne Govaarts, Elliz P Scheijbeler, Emma Beeldman, et al.
Environmental Health Perspectives|July 11, 2018
Long-Term Air Pollution Exposure and Amyotrophic Lateral Sclerosis in Netherlands: A Population-based Case-control StudyMeinie Seelen, Rosario A Toro Campos, Jan H Veldink, et al.
Journal of Neurology|February 8, 2017
No association between gluten sensitivity and amyotrophic lateral sclerosisAnne E Visser, Raha Pazoki, Sara L Pulit, et al.
Rheumatology (Oxford, England)|October 25, 2020
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot studyJohan Lim, Filip Eftimov, Camiel Verhamme, et al.
BMJ Open|February 6, 2025
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocolBettina C Geertsema-Hoeve, Jan A M van Laar, Joost Raaphorst, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophyJoost Raaphorst, Marianne de Visser, Marie-José van Tol, et al.
Rheumatology (Oxford, England)|December 7, 2021
Assessment of disability in idiopathic inflammatory myopathy: a call for linearityMinoesch Min, Anne W Walter, Johan Lim, et al.
Biomedicines|February 26, 2025
Methodology Development for Investigating Pathophysiological [<sup>18</sup>F]-FDG Muscle Uptake in Patients with Rheumatic Musculoskeletal DiseasesMaia Sobejana, Mustafa Al Beiramani, Gerben J C Zwezerijnen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2021
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysisBas C Stunnenberg, Esther C Merkus, Joost Raaphorst, et al.
Arthritis Research & Therapy|April 1, 2025
Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathwayAna Merino-Vico, Merve Kocyigit, Giulia Frazzei, et al.
Network Neuroscience (Cambridge, Mass.)|July 24, 2025
Longitudinal changes in MEG-based brain network topology of ALS patients with cognitive/behavioral impairment-An exploratory studyRosanne Govaarts, Elliz P Scheijbeler, Emma Beeldman, et al.
Environmental Health Perspectives|July 11, 2018
Long-Term Air Pollution Exposure and Amyotrophic Lateral Sclerosis in Netherlands: A Population-based Case-control StudyMeinie Seelen, Rosario A Toro Campos, Jan H Veldink, et al.
Journal of Neurology|February 8, 2017
No association between gluten sensitivity and amyotrophic lateral sclerosisAnne E Visser, Raha Pazoki, Sara L Pulit, et al.
Rheumatology (Oxford, England)|October 25, 2020
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot studyJohan Lim, Filip Eftimov, Camiel Verhamme, et al.
BMJ Open|February 6, 2025
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocolBettina C Geertsema-Hoeve, Jan A M van Laar, Joost Raaphorst, et al.
Pageof 9